Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients

NCT: NCT07641790 · RECRUITING

NCT IDNCT07641790
StatusRECRUITING
Start Date2026-02-01
Completion2026-07-15
SponsorUniversity of Faisalabad (OTHER)
First posted
Last updated

Brief Summary

Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.

Frequently Asked Questions

What is Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients?

Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients is a clinical trial registered under NCT07641790. Current status: RECRUITING.

What is the status of NCT07641790?

The current status of NCT07641790 (Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients) is: RECRUITING.

When did Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients start?

Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients started on 2026-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.